DiscoverJAMA Neurology Author InterviewsHigh-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

Update: 2024-03-25
Share

Description

Interview with Anne Kerbrat, MD, PhD, author of High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS. Hosted by Cynthia E. Armand, MD.

Related Content:

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS